This work was supported by a pilot grant from the HIV and Aging Grant CFAR-UAB (R24 AG044325), and a philanthropic donation received from the McNair Medical Institute at The Robert and Janice McNair Foundation.
These results position cagrilintide monotherapy as less effective than semaglutide for raw weight loss but still clinically significant and far superior to placebo
Glutathione (Included): The master antioxidant that detoxifies, strengthens liver function, and restores oxidative balance
Semaglutide (2 mg) is a synthetic peptide commonly studied in metabolic and endocrine research
Hormone therapy is not a universal dementia-prevention treatment
Common side effects observed in Phase 2 trials include nausea, vomiting, diarrhoea, and injection site reactions, particularly during dose escalation